CS Analytical CSO Brandon Zurawlow to Lead IPP Container Closure Integrity Testing (CCIT) Seminar

CS Analytical CSO Brandon Zurawlow to Lead IPP Container Closure Integrity Testing (CCIT) Seminar

Post Views: 239 CS Analytical Laboratory, the world’s only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that Chief Scientific Officer Brandon Zurawlow will lead the CCI training course at the Industrial Production Processes (IPP) Ltd Container Closure…

Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium

Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium

Post Views: 273 The Rett Syndrome Research Trust (RSRT) has joined the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP®BGTC), a public-private collaboration led by the Foundation for the National Institutes of Health (FNIH) and the National Institutes of Health (NIH), intended to accelerate new gene therapies for patients with rare diseases. RSRT is one…

Susan Almon-Pesch Named One of San Diego’s Top Marketing Executives 2022 by SD METRO Magazine

Susan Almon-Pesch Named One of San Diego’s Top Marketing Executives 2022 by SD METRO Magazine

Post Views: 240 SD METRO Magazine recognized Susan Almon-Pesch along with ten other talented PR and marketing executives in its January 2022 cover story featuring San Diego’s top professionals in the industry. Honoree, Almon-Pesch, is the owner of Market 4 Profit. Founded in San Diego, California in 1999, the marketing and public relations agency serves…

Hikma expands into Canada with acquisition of Teligent sterile injectable assets

Hikma expands into Canada with acquisition of Teligent sterile injectable assets

Post Views: 232 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has agreed to acquire the Canadian assets of Teligent Inc. (Teligent) for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. The acquisition marks Hikma’s expansion into Canada and includes a…

This algorithm knows about recreational drugs that don’t even exist yet

Post Views: 268 Novel designer drugs, also called research chemicals or legal highs, still produce physiological and psychological effects, though experts say that they can come with a slew of risks. Synthetic opioids such as fentanyl, for instance, are increasingly cited among the number of opioid-related deaths in the United States, which reached more than…